TY - JOUR
KW - 3383:Drug & Alcohol Rehabilitation
KW - Adulthood (18 yrs & older)
KW - article
KW - buprenorphine
KW - Detoxification
KW - Drug Administration Methods
KW - Drug Dependency
KW - Drug Withdrawal
KW - effectiveness evaluation
KW - Empirical Study
KW - Female
KW - Human
KW - Male
KW - Middle Age (40-64 yrs)
KW - Narcotic Agonists
KW - Narcotic Antagonists
KW - Opiates
KW - opioid dependence
KW - opioid detoxification
KW - Quantitative Study
KW - Thirties (30-39 yrs)
KW - transdermal buprenorphine formulation
KW - Treatment Effectiveness Evaluation
KW - Visual Analogue Scale
KW - Young Adulthood (18-29 yrs)
AU - Ryan K. Lanier
AU - Annie Umbricht
AU - Joseph A. Harrison
AU - Elie S. Nuwayser
AU - George E. Bigelow
A1 - 
BT - Addiction
C5 - Opioids & Substance Use
CP - 10
IS - 10
JF - Addiction
PB - Blackwell Publishing Wiley-Blackwell Publishing Ltd.
PY - 2007
SN - 0965-2140, 0965-2140
SP - 1648
EP - 1656
EP - 
T1 - Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
T2 - Addiction
TI - Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
U1 - Opioids & Substance Use
UR - http://search.proquest.com/docview/621865572?accountid=28100
VL - 102
VO - 0965-2140, 0965-2140
Y1 - 2007
ER -